Anti-Human GBA Recombinant Nanobody (SAA2277) (HY292013)

Name: Anti-Human GBA Recombinant Nanobody (SAA2277)
Brand: abinScience
SKU: HY292013
Price: 191 USD
Availability: InStock

데이터시트 제품 공유 정보 복사

가격(USD):

사양:

50ug
100ug
1mg

수량:

문의하기

개요
이미지
참고 문헌
데이터시트
SDS

개요

카탈로그 번호

HY292013

설명

Anti-Human GBA Nanobody (SAA2277) [SAA2277] (HY292013) is a alpaca monoclonal antibody detecting Human GBA in ELISA, BLI. Suitable for Human.

종 반응성

Human

응용 분야

ELISA, BLI

숙주 종

Alpaca

클론성

Monoclonal

이소타입

VHH-His

클론 ID

SAA2277

타겟

Lysosomal acid glucosylceramidase, Lysosomal acid GCase, EC:3.2.1.45, Acid beta-glucosidase, Alglucerase, Beta-glucocerebrosidase, Beta-GC, Beta-glucosylceramidase 1, Cholesterol glucosyltransferase, SGTase, EC:2.4.1.-, Cholesteryl-beta-glucosidase, EC:3.2.1.-, D-glucosyl-N-acylsphingosine glucohydrolase, Glucosylceramidase beta 1, Imiglucerase, Lysosomal cholesterol glycosyltransferase, Lysosomal galactosylceramidase, EC:3.2.1.46, Lysosomal glycosylceramidase, GBA1

내독소 수준

Please contact with the lab for this information.

순도

>90% as determined by SDS-PAGE.

정제

Purified by Nickel column.

등록번호

P04062

형태

Liquid

저장 완충액

0.01M PBS pH 7.4

데이터시트 인쇄본 또는 로트별 COA에 기재된 구체적인 완충액 정보를 참조하세요.

제품 사용 정보

응용 분야	희석
ELISA	1:2000-1:20000

안정성 및 저장

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

배경

Lysosomal acid glucosylceramidase (GBA) is a ~59 kDa protein. Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramides/GlcCers (such as beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine) into free ceramides (such as N-acylsphing-4-enine) and glucose. Plays a central role in the degradation of complex lipids and the turnover of cellular membranes. Through the production of ceramides, participates in the PKC-activated salvage pathway of ceramide formation. Catalyzes the glucosylation of cholesterol, through a transglucosylation reaction where glucose is transferred from GlcCer to cholesterol. GlcCer containing mono-unsaturated fatty acids (such as beta-D-glucosyl-N-(9Z-octadecenoyl)-sphing-4-enine) are preferred as glucose donors for cholesterol glucosylation when compared with GlcCer containing same chain length of saturated fatty acids (such as beta-D-glucosyl-N-octadecanoyl-sphing-4-enine).

1. Ron, I. et al. (2005) Blood cells, molecules & diseases 35, 57-65. PMID: 15916907

2. Akiyama, H. et al. (2013) Biochemical and biophysical research communications 441, 838-43. PMID: 24211208

3. Akiyama, H. et al. (2020) The Journal of biological chemistry 295, 5257-5277. PMID: 32144204

4. Bannink, S. et al. (2024) Journal of lipid research 65, 100670. PMID: 39395789

5. Vaccaro, AM. et al. (1997) The Journal of biological chemistry 272, 16862-7. PMID: 9201993

6. Magalhaes, J. et al. (2016) Human molecular genetics 25, 3432-3445. PMID: 27378698

7. Kitatani, K. et al. (2009) The Journal of biological chemistry 284, 12972-8. PMID: 19279011

8. Marques, AR. et al. (2016) Journal of lipid research 57, 451-63. PMID: 26724485

9. Boer, DE. et al. (2021) Journal of lipid research 62, 100018. PMID: 33361282

참고사항

For research use only.

이미지

SDS-PAGE

SDS-PAGE for Anti-Human GBA Nanobody (SAA2277)

참고 문헌

데이터시트

Anti-Human GBA Recombinant Nanobody (SAA2277).pdf

Download SDS PDF

Formula

Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)

Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.

Mass

Concentration

Volume

Molecular Weight *

g/mol

Formula

C₁ × V₁ = C₂ × V₂

Enter any 3 of the 4 values to solve for the unknown.

Stock Solution

C₁ (Stock Conc.)

V₁ (Stock Vol.)

Working Solution

C₂ (Working Conc.)

V₂ (Working Vol.)

재조합 단백질

항체

어세이 키트

Anti-Human GBA Recombinant Nanobody (SAA2277) (HY292013)

개요

이미지

참고 문헌

데이터시트

SDS

빠른 접근

문의하기